A new preclinical study has uncovered an unexpected link between chronic psychological stress, gut microbes, and cancer progression, revealing how prolonged stress may help tumors evade the immune defences of the body. Published in Cancer Cell, the research, suggests that chronic stress alters the behavior of gut bacteria, enabling them to migrate to tumors where they trigger a chain of events that suppresses anti-cancer immunity. The findings not only deepen our understanding of cancer biology but also open new avenues for therapeutic interventions and diagnostic strategies.
Cancer patients frequently experience sustained psychological stress, yet the biological mechanisms connecting stress with tumor progression have remained poorly understood. According to the researchers, chronic stress can disrupt the balance of the gut microbiota, allowing certain bacteria to escape the intestine and colonize tumors. Once inside the tumor microenvironment, these bacteria and the viruses they carry interact with surrounding cells to create conditions that favor tumor survival.
Using mouse models of cancer exposed to chronic unpredictable mild stress, the researchers observed a marked reduction in the activity of B cells, a type of immune cell responsible for producing antibodies that help recognize and eliminate cancer cells. Further investigation revealed elevated levels of glucocorticoids, stress hormones typically produced by the adrenal glands, not only in circulation but also within the tumors themselves. Surprisingly, hormone concentrations inside the tumors exceeded those in nearby healthy tissues, indicating that the tumors had become local sites of stress hormone production.
To determine the role of gut microbes in this process, the investigators studied germ-free mice and mice treated with broad-spectrum antibiotics. In both cases, the stress-induced suppression of anti-tumor immunity was significantly diminished, suggesting that gut bacteria were essential for the observed effects.
The researchers then mapped the sequence of events underlying this phenomenon. Chronic stress first stimulates the adrenal glands to release glucocorticoids, which increase stress hormone levels in the intestine. These hormones activate glucocorticoid receptors on intestinal lining cells, weakening the gut barrier. As a result, specific gut bacteria are able to escape into the bloodstream and migrate to distant tissues, including tumors.
Among the bacterial species identified, Enterococcus gallinarum emerged as the predominant organism migrating from the gut to tumors in mouse models. However, the bacteria themselves were only part of the story. Many bacteria naturally harbor bacteriophages, viruses that infect bacterial cells. Within tumors, these phages were found to burst from E. gallinarum, releasing viral DNA into the surrounding tissue.
The released phage DNA activated Toll-like receptor 9 (TLR9) on cancer-associated fibroblasts (CAFs), specialized cells that support tumor growth. Activation of TLR9 stimulated CAFs to produce high levels of glucocorticoids directly within the tumor. These locally produced stress hormones suppressed B-cell-mediated anti-tumor immunity, allowing tumors to evade immune surveillance more effectively.
The researchers found evidence that a similar mechanism may occur in humans. Analysis of human colorectal tumor samples identified Klebsiella pneumoniae carrying bacteriophages, and when introduced into mice, this bacterium significantly accelerated tumor growth. In addition, genomic analysis of human brain tumor samples suggested the presence of another gut bacterium, Enterococcus faecium, along with its associated phages, indicating that multiple bacterial species may contribute to this pathway.
The findings also point toward several potential therapeutic strategies. In mouse models, blocking TLR9 signaling effectively interrupted the immune-suppressive cascade. Similarly, directly injecting antibiotics into tumors to eliminate resident bacteria restored aspects of anti-tumor immunity. These results suggest that targeting tumor-associated bacteria, bacteriophages, or TLR9 signaling could complement existing cancer immunotherapies.
Researchers are now investigating which therapeutic approach offers the greatest clinical potential and whether detecting bacteriophages within tumors could serve as a prognostic biomarker for disease progression or treatment response.
Beyond identifying new treatment targets, the study highlights the broader importance of psychological well-being in cancer care. The authors suggest that effective stress management may play a role in preserving anti-tumor immunity. They also raise important questions about the clinical use of glucocorticoids, which are commonly prescribed to cancer patients to reduce inflammation and manage treatment-related side effects.
While additional clinical studies are needed to validate these findings in humans, the research provides compelling evidence that the interaction between chronic stress, the gut microbiome, and the immune system is more intricate than previously recognized. By revealing how gut bacteria and their viruses can reshape the tumor microenvironment under stress, the study offers a promising new perspective on improving cancer treatment and patient outcomes.
References
- Bashir H, Sanidad KZ, Ravisankar P, Banks KM, Bose A, Yu S, et al. Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth. Cancer Cell. 2026 Jun 25. doi:10.1016/j.ccell.2026.06.004.